A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment

BACKGROUND: Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazoline that provides up to 12 weeks flea and tick control when administered orally to dogs. Two assessor-blinded studies, one in dogs, the other in cats evaluated the sustained efficacy of a topical fluralaner...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Sivaja, Young, David, Sun, Fangshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029119/
https://www.ncbi.nlm.nih.gov/pubmed/29970135
http://dx.doi.org/10.1186/s13071-018-2927-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029119/
https://www.ncbi.nlm.nih.gov/pubmed/29970135
http://dx.doi.org/10.1186/s13071-018-2927-0

Ejemplares similares